Abstract
The mRNA levels of LIV-1 and pS2, two estrogen-responsive genes, are increased by the agents, cholera toxin (CT) plus 3-isobutyl-l-methylxanthine (IBMX), which cause an increase in cAMP in MCF-7 human breast cancer cells. The simultaneous addition of estradiol and CT/IBMX results in a synergistic induction of the two mRNAs. The changes in mRNA reflect changes in transcription of the two genes. Interestingly, the addition of CT/IBMX to estradiol not only causes a greater increase in transcription rate but the increase is longer-lasting that seen with the hormone alone. Stimulation of mRNA levels by CT/IBMX, but not by estradiol, was prevented by cycloheximide. Stimulation by both estradiol and by CT/IBMX was prevented by the antiestrogen, ICI 164387. Transcription of LIV-1 and pS2 genes is by both estradiol and cAMP, via separate mechanisms both requiring the estrogen receptor.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
1-Methyl-3-isobutylxanthine / pharmacology
-
Breast Neoplasms
-
Carcinoma
-
Cholera Toxin / pharmacology
-
Cyclic AMP / physiology*
-
Cycloheximide / pharmacology
-
Estradiol / analogs & derivatives
-
Estradiol / pharmacology*
-
Estrogen Antagonists / pharmacology
-
Gene Expression Regulation, Neoplastic / drug effects
-
Gene Expression Regulation, Neoplastic / physiology*
-
Humans
-
Neoplasm Proteins / genetics*
-
Phosphodiesterase Inhibitors / pharmacology
-
Polyunsaturated Alkamides
-
Protein Synthesis Inhibitors / pharmacology
-
Proteins*
-
RNA, Messenger / biosynthesis
-
RNA, Neoplasm / biosynthesis
-
Receptors, Estradiol / physiology
-
Trefoil Factor-1
-
Tumor Cells, Cultured
-
Tumor Suppressor Proteins
Substances
-
Estrogen Antagonists
-
Neoplasm Proteins
-
Phosphodiesterase Inhibitors
-
Polyunsaturated Alkamides
-
Protein Synthesis Inhibitors
-
Proteins
-
RNA, Messenger
-
RNA, Neoplasm
-
Receptors, Estradiol
-
TFF1 protein, human
-
Trefoil Factor-1
-
Tumor Suppressor Proteins
-
Estradiol
-
ICI 164384
-
Cholera Toxin
-
Cycloheximide
-
Cyclic AMP
-
1-Methyl-3-isobutylxanthine